Related Experiment Video
Updated: Jan 9, 2026

Intrarenal Injection of Escherichia coli in a Rat Model of Pyelonephritis
Published on: July 18, 2017
A Case of Pediatric Yersinia pseudotuberculosis Infection Complicated by Acute Kidney Injury Successfully Treated
Takuma Ohnishi1,2, Satoshi Sato1, Yoji Uejima1
1Department of Infectious Diseases, Immunology, and Allergy, Saitama Children's Medical Center, Saitama, JPN.
Insights
A three-year-old boy with Yersinia pseudotuberculosis (Y. pstb) infection developed acute kidney injury (AKI). Prompt treatment with prednisolone improved renal function, avoiding dialysis and suggesting immune-mediated mechanisms.
Area of Science:
- Pediatric Nephrology
- Infectious Diseases
- Immunology
Background:
- Yersinia pseudotuberculosis (Y. pstb) infection can cause gastroenteritis and acute kidney injury (AKI) in children.
- AKI in pediatric patients may arise from complex mechanisms, including immune responses.
- The Yersinia-derived mitogen (YPM) is implicated in superantigenic immune activation.
Abstract:
Yersinia pseudotuberculosis (Y. pstb) infection causes bacterial gastroenteritis and may lead to complications, including acute kidney injury (AKI). We report a case of a previously healthy three-year-old boy presenting with prolonged fever, abdominal distention, generalized edema, and impaired renal function following gastroenteritis symptoms. Laboratory tests indicated severe inflammation and AKI, classified as renal failure by the pediatric-modified Risk, Injury, Failure, Loss, End-Stage Renal Disease (RIFLE) AKI classification system. Intravenous prednisolone rapidly improved clinical symptoms and renal function, eliminating the need for renal replacement therapy. Elevated serum anti-Y. pstb-derived mitogen (YPM) antibody titers confirmed the diagnosis. Pediatric AKI due to Y. pstb infection may involve immune-mediated mechanisms triggered by YPM. In this case, systemic glucocorticoid therapy effectively controlled the inflammatory response and restored renal function, without dialysis. Together with prior evidence that the YPM drives superantigenic immune activation in severe presentations, this case supports consideration of prednisolone as a dialysis-sparing option in select pediatric Y. pstb-associated AKI.
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury I: Introduction
Acute Pyelonephritis II: Diagnostic Studies and Management
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury II: Pathophysiology

